{"schema":"rootz.ai/sec-company/v1","layer":0,"identity":{"name":"Akebia Therapeutics, Inc.","cik":"0001517022","ticker":"AKBA","exchange":"Nasdaq","sic":"2834","sic_description":"Pharmaceutical Preparations","state_of_incorporation":"DE","headquarters":null,"founded":null,"ipo_date":null,"status":"active"},"summary":"PART I Overview We are a fully integrated biopharmaceutical company with two commercial products for patients impacted by kidney disease. We have built a business focused on developing and commercializing innovative therapeutics that we believe serve as a foundation for future growth, including by contributing net product revenue to support the development and advancement of our robust pipeline of mid-stage programs targeting rare kidney diseases and early-stage programs targeting kidney disease...","peak_metrics":{"market_cap_usd":null,"market_cap_date":null,"employees":null,"employees_date":null,"rd_spend_usd":null,"rd_spend_year":null},"tags":[],"deeper":{"profile":"/api/company/AKBA/profile","timeline":"/api/company/AKBA/timeline","filings":"/api/company/AKBA/filings","people":"/api/company/AKBA/people","skill":"/api/skills/AKBA","skill_json":"/api/skills/AKBA?format=json"},"data_freshness":{"latest_filing":"2026-08-05","latest_extracted":"2026-04-01","latest_quote":"2026-08-20","warning":"New filing(s) detected (2026-08-05) but not yet extracted. Latest extracted data is from 2026-04-01. Extraction runs 3x daily.","stale":true},"origin":{"leaf":"6e0543a019aa42f6d4b6cf8af78d817d4336f753e82f77ddec74c9a97ebaf5e0","parent":"630f41481b6cef9f46fe812cea26a686ed0b749d796c48c731c688aa23997211","timestamp":"2026-08-26T23:09:36.812Z","source":"0001517022-26-000020","chain":"SEC.gov PEM > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":249,"hourly_limit":500,"remaining":251,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}